All the Active Ingredient Drugs
Tyrosine Kinase Inhibitor, VEGF Inhibitor. Axitinib 1 mg, 5 mg. FC. TAB 60 X 1/5 mg
Recomm. starting dose is 5 mg twice/d. Administer doses approx. 12 hs apart. Dose incr. or reduct. is based on indiv. safety and tolerab. See full prescript. data
Tmt. of adv.renal cell carcinoma (RCC) after failure of one prior syst. ther.
C/I: Hypersens.
Tyrosine Kinase Inhibitor. Axitinib 1 mg, 5 mg. F.C. TAB: 28, 56, 60, 180 × 5, 1 mg.
Recomm. init. oral dose is 5 mg×2/d. approx. 12 hrs. apart with/without food. Should be swallow. whole with a glass of water. If the pt. vomits or misses a dose, an addit. dose should not be taken. The next prescribed dose should be taken at the usual time. See lit.
Tmt. of advanc. RCC after fail. of one prior syst. therapy.
C/I: Hypersens.
